IPO Plus

₹1,940.7

▲ +53.59 +2.84%

06 Aug 2026

NSE Listed · Healthcare

Dr. Lal PathLabs Limited (LALPATHLAB)

Volume: 1,51,179Avg Vol 1W: 4,08,756Avg Vol 1M: 4,68,46752W Range:₹1,272.6₹1,955.1
NSE BSE www.lalpathlabs.com AI Report
Key Ratios
Checked just now
Market Cap₹32,330 Cr
Current Price₹1,940.7
Previous Close₹1,887.11
High / Low (52w)₹1,955.1 / ₹1,272.6
Volume1,51,179
Avg Vol (1W)4,08,756
Avg Vol (1M)4,68,467
Stock P/E59.93
Book Value₹150.21
Dividend Yield1.05%
ROE20.13%
ROA16.2%
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt₹0 Cr
Shares Outstanding17 Cr
Face Value₹10
EPS (TTM)₹32.31
P/B12.89
Debt / Equity7.83
50 DMA₹1,689.73
200 DMA₹1,518.89
Day change+2.84%
Price Chart
₹1,940.7▲ 20.96% · 1Y
₹2442₹130886.8L
2025-08-06
2026-08-06

20-day avg volume: 4.9L shares

Pros
  • Healthy return on equity of 20.1%.
  • Company is almost debt-free.
  • Revenue grew 12% YoY.
Cons
  • Stock trades at a high P/E of 60.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹660 Cr₹597 Cr₹603 Cr₹670 Cr₹731 Cr₹660 Cr₹703 Cr₹798 Cr
EBITDA₹189 Cr₹144 Cr₹158 Cr₹186 Cr₹208 Cr₹162 Cr₹166 Cr₹235 Cr
Net Profit₹129 Cr₹97 Cr₹155 Cr₹132 Cr₹151 Cr₹91 Cr₹131 Cr₹170 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹2,555 Cr₹577 Cr₹641 Cr₹700 Cr₹632 Cr₹675 Cr₹2,864 Cr₹764 Cr
EBITDA₹647 Cr₹150 Cr₹177 Cr₹199 Cr₹160 Cr₹176 Cr₹722 Cr₹228 Cr
Net Profit₹487 Cr₹148 Cr₹129 Cr₹146 Cr₹92 Cr₹141 Cr₹505 Cr₹166 Cr
EPS58.4—————30.2—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹1,091 Cr₹1,374 Cr₹1,661 Cr₹2,353 Cr₹2,386 Cr₹2,456 Cr₹2,717 Cr₹3,146 Cr
Total Liabilities₹140 Cr₹320 Cr₹385 Cr₹810 Cr₹686 Cr₹571 Cr₹510 Cr₹605 Cr
Equity₹951 Cr₹1,054 Cr₹1,276 Cr₹1,544 Cr₹1,700 Cr₹1,885 Cr₹2,206 Cr₹2,541 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹323 Cr₹377 Cr₹500 Cr₹577 Cr₹562 Cr₹667 Cr₹733 Cr₹811 Cr
Investing₹-100 Cr₹-26 Cr₹-212 Cr₹-449 Cr₹-287 Cr₹-24 Cr₹-303 Cr₹-422 Cr
Financing₹-55 Cr₹-190 Cr₹-139 Cr₹136 Cr₹-283 Cr₹-414 Cr₹-334 Cr₹-264 Cr
Free Cash Flow₹323 Cr₹377 Cr₹500 Cr₹577 Cr₹562 Cr₹667 Cr₹733 Cr₹811 Cr
Shareholding
Promoter 54.91% Institutions 32.14% Public 12.95%
About Dr. Lal PathLabs Limited

Healthcare · Diagnostics & Research

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.

www.lalpathlabs.com ↗
Efficiency & Working Capital
ROCE29.7%
Interest Coverage30.4
Dividend Payout—
Debtor Days15 d
Inventory Days6 d
Payable Days24 d
Cash Conversion Cycle-3 d
Working Capital Days20 d
Shareholding Details

As of 2026-06-30

Promoter53.2%
FII17.4%
DII21.6%
Institutions39%
Public7.9%
Promoter Pledge0%
No. of Shareholders1,11,037
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters54.6%54.6%54.6%54.6%53.9%53.9%53.9%53.8%53.2%53.2%53.2%53.2%
FIIs24.4%25.4%26.2%25.4%26.8%26.8%23.9%21.7%21.9%20.3%17.2%17.4%
DIIs8%8.6%9.7%12.7%12.9%13.2%16.1%17.9%18.5%19.2%21.4%21.6%
Public13.1%11.4%9.6%7.3%6.4%6.1%6.1%6.6%6.4%7.3%8.2%7.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,60,6791,49,9011,46,7411,31,1891,16,6061,16,2361,15,6991,18,6561,12,7031,16,1671,14,5271,11,037
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Arvind LalShareholding of Promoter and Promoter Group30.1%5.05 Cr
Vandana LalShareholding of Promoter and Promoter Group19.2%3.22 Cr
Hdfc Mutual Fund - Hdfc Retirement Savings Fund - Equity PlanPublic Shareholding3.9%65,55,612
Uti-mid Cap FundPublic Shareholding2.6%44,30,364
Nippon Life India Trustee Ltd-a/c Nippon India Pharma FundPublic Shareholding2.6%44,15,617
Anjaneya LalShareholding of Promoter and Promoter Group2%33,79,228
Smallcap World Fund, IncPublic Shareholding2%33,17,603
Archana Lal ErdmannShareholding of Promoter and Promoter Group1.8%30,87,502
Aditya Birla Sun Life Trustee Private Limited A/c Aditya Birla Sun Life Small Cap FundPublic Shareholding1.8%29,79,002
Life Insurance Corporation Of IndiaPublic Shareholding1.5%24,62,492
Titanium Hybrid Long-short FundPublic Shareholding1.4%23,64,311
Sbi Nifty Smallcap 250 EtfPublic Shareholding1.4%23,24,583
Invesco Oppenheimer International Growth FundPublic Shareholding1.4%22,90,064
Board of Directors
NameDesignationYear
Arvind LalChairman/ED & CEO2026
Vandana LalWTD & Executive Director2026
Arun DuggalLead Independent Non Executive Director2026
Rohit BhasinIndependent Non Exe. Director2026
Somya SatsangiIndependent Non Exe. Director2026
Gurinder Singh KalraIndependent Non Exe. Director2026
RAJIT MEHTAIndependent Non Exe. Director2026
Archana Lal ErdmannNon Executive Director2026
Rahul SharmaNon Executive Director2026
Vinay GujralCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Running laboratories for carrying o₹0 Cr—
Segments — Geography
RegionRevenueShare
India₹2,615 Cr98.8%
Outside India₹32 Cr1.2%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10200168168
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-30Dividend (5/- per share)Interim
dividend2026-07-30₹5 (50%)Interim
forthcoming2026-07-24Board Meetings—
dividend2026-06-25₹4 (40%)Final
dividend2026-06-25₹4.0 (40.0%)Final
dividend2026-02-05₹3.5 (35%)Interim 3
bonus2025-12-191:11:1 Bounus Issue of Equity Shares
dividend2025-11-07₹7 (70%)Interim 2
dividend2025-08-06₹6 (60%)Interim
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026730013210224
202600001010
20267001320148
Insider / Designated-Person Trades

139 recent disclosure(s)

Reena NakraDisposal · 1,078
Prashant KishoreAcquisition · 872
Prashant KishoreDisposal · 600
Satish Kumar SinghAcquisition · 1,474
Dr. Lal PathLabs Employee Welfare TrustDisposal · 2,346
Abhishek MainiDisposal · 500
Substantial Acquisitions (SAST)

1 disclosure(s)

Market13/09/2024 · 1,57,500
Company Information
Incorporated1995
ChairmanArvind Lal
AuditorDeloitte Haskins & Sells LLP
Investor Email[email protected]
🌐 www.lalpathlabs.com ↗

📍 E-2 Block Sector 18, Rohini, New Delhi, New Delhi, 110085

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Kwality Walls (India) LimitedLagnam Spintex LimitedLahoti Overseas Ltd.Lakshmi Precision Screws Ltd.Lakshya Powertech LimitedLorenzini Apparels Ltd.Lambodhara Textiles Ltd.Lamosaic India LimitedLancor Holdings LimitedLandmark Cars LimitedLandsmill Green LimitedLa Opala RGAll “L” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Telegram App